What's new

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 5, Status: Authorised

Mar 26, 2025 - 09:21
 0
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

MedDRA important medical event terms list - version 28.1

Next Article

Santa Rita’s new CEO shares premiumisation plans

Related Posts

Template for assessment report for the development of European Union herbal monographs and list entries

Template for assessment report for the development of E...

Feb 17, 2025  0

Seizing opportunities in a changing medicines landscape...

Mar 18, 2025  0

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0